156 related articles for article (PubMed ID: 32747497)
1. B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial.
Hubers SA; Schirger JA; Sangaralingham SJ; Chen Y; Burnett JC; Hodge D; Chen HH
Heart; 2021 Mar; 107(5):396-402. PubMed ID: 32747497
[TBL] [Abstract][Full Text] [Related]
2. B-type natriuretic peptide infusions in acute myocardial infarction.
Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
[TBL] [Abstract][Full Text] [Related]
3. Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study.
Chen HH; Martin FL; Gibbons RJ; Schirger JA; Wright RS; Schears RM; Redfield MM; Simari RD; Lerman A; Cataliotti A; Burnett JC
Heart; 2009 Aug; 95(16):1315-9. PubMed ID: 19447837
[TBL] [Abstract][Full Text] [Related]
4. Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial.
Tuñón J; González-Hernández I; Llanos-Jiménez L; Alonso-Martín J; Escudier-Villa JM; Tarín N; Cristóbal C; Sanz P; Pello AM; Aceña Á; Carda R; Orejas M; Tomás M; Beltrán P; Calero Rueda M; Marcos E; Serrano-Antolín JM; Gutiérrez-Landaluce C; Jiménez R; Cabezudo J; Curcio A; Peces-Barba G; González-Parra E; Muñoz-Siscart R; González-Casaus ML; Lorenzo A; Huelmos A; Goicolea J; Ibáñez B; Hernández G; Alonso-Pulpón LM; Farré J; Lorenzo Ó; Mahíllo-Fernández I; Egido J
BMJ Open; 2016 Aug; 6(8):e011287. PubMed ID: 27496232
[TBL] [Abstract][Full Text] [Related]
5. Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial.
Nicolau JC; Furtado RHM; Silva SA; Rochitte CE; Rassi A; Moraes JBMC; Quintella E; Costantini CR; Korman APM; Mattos MA; Castello HJ; Caixeta A; Dohmann HFR; de Carvalho ACC;
Clin Cardiol; 2018 Mar; 41(3):392-399. PubMed ID: 29569254
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of a randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of B-type natriuretic peptide for the preservation of left ventricular function after anterior myocardial infarction.
Sangaralingham SJ; Burnett JC; McKie PM; Schirger JA; Chen HH
J Card Fail; 2013 Aug; 19(8):533-9. PubMed ID: 23910581
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular responses to acute changes in late systolic pressure augmentation in older adults.
Sweitzer NK; Hetzel SJ; Skalski J; Velez M; Eggleston K; Mitchell GF
Am J Hypertens; 2013 Jul; 26(7):866-71. PubMed ID: 23537892
[TBL] [Abstract][Full Text] [Related]
8. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
9. Changes in B-type natriuretic peptides after surgical ventricular restoration.
Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
[TBL] [Abstract][Full Text] [Related]
10. Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury.
George I; Morrow B; Xu K; Yi GH; Holmes J; Wu EX; Li Z; Protter AA; Oz MC; Wang J
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H708-17. PubMed ID: 19525373
[TBL] [Abstract][Full Text] [Related]
11. Effect of Paroxetine-Mediated G-Protein Receptor Kinase 2 Inhibition vs Placebo in Patients With Anterior Myocardial Infarction: A Randomized Clinical Trial.
Pilgrim T; Vollenbroich R; Deckarm S; Gräni C; Dobner S; Stark AW; Erne SA; Babongo Bosombo F; Fischer K; Stortecky S; Reusser N; Fürholz M; Siontis GCM; Heg D; Hunziker L; Windecker S; Lanz J
JAMA Cardiol; 2021 Oct; 6(10):1171-1176. PubMed ID: 34259826
[TBL] [Abstract][Full Text] [Related]
12. Human recombinant-B-type natriuretic peptide protect ventricular function and structure in ST-elevation myocardial infarction.
Gong X; Mou Z; Shao L; Zou Y; Gu Y; Sun S
Int J Clin Exp Pathol; 2015; 8(9):11622-8. PubMed ID: 26617900
[TBL] [Abstract][Full Text] [Related]
13. Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial.
Jabbar A; Ingoe L; Junejo S; Carey P; Addison C; Thomas H; Parikh JD; Austin D; Hollingsworth KG; Stocken DD; Pearce SHS; Greenwood JP; Zaman A; Razvi S
JAMA; 2020 Jul; 324(3):249-258. PubMed ID: 32692386
[TBL] [Abstract][Full Text] [Related]
14. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats.
He J; Chen Y; Huang Y; Yao F; Wu Z; Chen S; Wang L; Xiao P; Dai G; Meng R; Zhang C; Tang L; Huang Y; Li Z
Eur J Pharmacol; 2009 Jan; 602(1):132-7. PubMed ID: 19027731
[TBL] [Abstract][Full Text] [Related]
16. Chronic Peptide Therapy With B-Type Natriuretic Peptide in Patients With Pre-Clinical Diastolic Dysfunction (Stage B Heart Failure).
Wan SH; McKie PM; Schirger JA; Slusser JP; Hodge DO; Redfield MM; Burnett JC; Chen HH
JACC Heart Fail; 2016 Jul; 4(7):539-547. PubMed ID: 26874387
[TBL] [Abstract][Full Text] [Related]
17. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction.
Giallauria F; De Lorenzo A; Pilerci F; Manakos A; Lucci R; Psaroudaki M; D'Agostino M; Del Forno D; Vigorito C
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):625-32. PubMed ID: 16874155
[TBL] [Abstract][Full Text] [Related]
18. Sustained elevation of plasma brain natriuretic peptide levels associated with progressive ventricular remodelling after acute myocardial infarction.
Nagaya N; Goto Y; Nishikimi T; Uematsu M; Miyao Y; Kobayashi Y; Miyazaki S; Hamada S; Kuribayashi S; Takamiya M; Matsuo H; Kangawa K; Nonogi H
Clin Sci (Lond); 1999 Feb; 96(2):129-36. PubMed ID: 9918892
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
[TBL] [Abstract][Full Text] [Related]
20. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J
Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
